Comparison of the effectiveness of conbercept and ranibizumab treatment for retinopathy of prematurity-Reference-Cited by-同舟云学术

Comparison of the effectiveness of conbercept and ranibizumab treatment for retinopathy of prematurity

Published:2020-05-08 Issue:8 Volume:98 Page:
ISSN:1755-375X
Container-title:Acta Ophthalmologica
language:en
Short-container-title:Acta Ophthalmol.

Author:

Cheng Yong¹,Zhu Xuemei¹,Linghu Dandan¹,Liang Jianhong¹^ORCID

Affiliation:

1. Peking University People’s Hospital Eye diseases and Optometry Institute Beijing Key Laboratory of Diagnosis and Therapy of Retinal and Choroid Diseases Department of Ophthalmology & Clinical Centre of Optometry College of Optometry Peking University Health Science Center Beijing China

Publisher

Wiley

Subject

Ophthalmology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/aos.14460

Reference24 articles.

1. The Process of Retinal Vascularization after Anti-VEGF Treatment in Retinopathy of Prematurity: A Comparison Study between Ranibizumab and Bevacizumab

2. Efficacy of intravitreal conbercept injection in the treatment of retinopathy of prematurity

3. Potential Role of Microglia in Retinal Blood Vessel Formation

4. A lower dose of intravitreal conbercept effectively treats retinopathy of prematurity

5. Loss of HIF-2α and inhibition of VEGF impair fetal lung maturation, whereas treatment with VEGF prevents fatal respiratory distress in premature mice

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of ranibizumab and conbercept treatment in type 1 prethreshold retinopathy of prematurity in zone II;BMC Pediatrics;2024-08-30

2. Vascular development analysis: a study for tertiary anti-vascular endothelial growth factor therapy after second reactivation of retinopathy of prematurity;Frontiers in Medicine;2024-07-19

3. Prediction of Reactivation after Anti-VEGF Monotherapy for Retinopathy of Prematurity Using Multimodal Machine Learning models (Preprint);2024-05-11

4. Comparison of different agents and doses of anti-vascular endothelial growth factors (aflibercept, bevacizumab, conbercept, ranibizumab) versus laser for retinopathy of prematurity: A network meta-analysis;Survey of Ophthalmology;2024-03

5. Efficacy of four anti-vascular endothelial growth factor agents and laser treatment for retinopathy of prematurity: A network meta-analysis;Biomolecules and Biomedicine;2023-11-16